2025 Oncology Institute
April 30, 2025 | 5:16 AM EST
- Home
- Clinical Resources Search
- The PQI Podcast S4 Ep 1: Drugs and the FDA
S4 Ep 1: Drugs and the FDA
Last Updated: January 19, 2023
By: Ginger Blackmon, PharmD | Dr. Mikkael Sekeres
In this episode, we sit down with Dr. Mikkael Sekeres to discuss his latest book Drugs and the FDA.
Dr. Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and former Chair of the Oncologic Drugs Advisory Committee of the FDA. A regular contributor to the Well section of the New York Times, he is the author of When Blood Breaks Down: Life Lessons from Leukemia (MIT Press).
More information on Drugs and the FDA can be found here.
Find Similar Resources
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 04/30/2025
PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations
Author: Florida Cancer Specialists & Research Institute, FL | Mayo Clinic, MN | Texas Oncology, TX
Last Updated: 04/30/2025
PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease
Author: University of Michigan Health-Sparrow Herbert-Herman Cancer Center, MI | Texas Oncology, TX | University of North Carolina (UNC) Health, NC
Last Updated: 04/30/2025
PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma
Author: Texas Oncology, TX | Florida Cancer Specialists & Research Institute, FL | University Hospitals Cleveland Medical Center, OH
Last Updated: 04/30/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024
Author: Ginger Blackmon, PharmD | Madison Marsh
Last Updated: 04/30/2025
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 04/30/2025
The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program
Author: Ginger Blackmon, PharmD | Salvatore Bottiglieri, PharmD, BCOP
Last Updated: 04/30/2025
The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings
Author: Ginger Blackmon, PharmD | Shana O. Ntiri, MD, MPH, FAAFP,
Last Updated: 04/30/2025
PQI Podcast
PQI
PQI in Action
PQI Podcast
The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024
Author: Ginger Blackmon, PharmD | Madison Marsh
Last Updated: 04/30/2025
PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 04/30/2025
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 04/30/2025
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 04/30/2025